Dr. Lori Amanda Cory, MD

Dr. Cory practices at Penn Medicine Lancaster General Health Physicians Gynecologic Oncology in Lancaster, Pennsylvania.

Dr. Cory's NPI, 1770873085, was assigned on April 8, 2011. Dr. Cory graduated from Perelman School of Med at the University of Pennsylvania in 2011. Dr. Cory holds Pennsylvania license MD454317.

Dr. Cory's primary practice is Penn Medicine Lancaster General Health Physicians Gynecologic Oncology, at 2102 Harrisburg Pike, Lancaster, PA 17601 in Lancaster County. The practice phone is (717) 544-0340.

Dr. Cory's primary practice is Penn Medicine Lancaster General Health Physicians Gynecologic Oncology in Lancaster, Pennsylvania. Dr. Cory is also affiliated with Lancaster General Hospital. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Cory to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cory practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Cory's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Cory is licensed in Pennsylvania.

CMS data shows 344 Medicare services from Dr. Cory across 5 procedure codes in 2024, for 97 Medicare patients. Medicare paid $19,026 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Cory in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cory's median patient age at 65, with 99% women.

In 2024, Dr. Cory wrote 84 Medicare Part D claims for 45 patients. 98% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $83 in total drug cost. In 2022, CMS named 39 claims across 2 drugs.

Dr. Cory accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 40 papers to Dr. Cory, published from 2011 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Ovarian Neoplasms, Endometrial Neoplasms and Hysterectomy. Dr. Cory has published most often in Int J Gynecol Cancer. Dr. Cory's most frequent co-authors are Emily M. Ko, MD, Dimitrios Nasioudis, MD and Lily A. Arya, MD.

CMS Open Payments shows 9 general payments to Dr. Cory from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $125.

Dr. Cory graduated from Perelman School of Med at the University of Pennsylvania in 2011.